Tıp Fakültesi / Faculty of Medicine
Permanent URI for this collectionhttps://hdl.handle.net/11727/1403
Browse
61 results
Search Results
Item Predisposing Risk Factors for Isolated Bile Leakage After Pancreaticoduodenectomy(2023) Aydin, Huseyin Onur; Soy, Ebru Hatice Ayvazoglu; Kirnap, Mahir; Moray, Gokhan; 38131350AIM: Isolated bile leakage (IBL) from hepaticojejunostomy, following pancreaticoduodenectomy, is a serious complication that increases morbidity and mortality. We aimed to assess the frequency of IBL development after pancreaticoduodenectomy and its underlying factors. MATERIALS AND METHODS: Patients who underwent pancreaticoduodenectomy for pancreatic diseases between January 2005 and January 2016 were retrospectively evaluated. Patients were dichotomized according to those with and without postoperative IBL. RESULTS: In the 111 patients who underwent pancreaticoduodenectomy during our study period, 8 patients (7.2%; 5 men/3 women) developed IBL. Risk of IBL development was significantly elevated among male patients, those with pre-operative serum albumin < 3.5 g/dL, and those with previous cholangitis (P < 0.05). DISCUSSION: Male sex, preoperatively low levels of serum albumin, and preoperative history of cholangitis can be listed as risk factors for IBL development. Physicians should pay attention to the risk of postoperative IBL development in such patients.Item Association Between Vitamin D Deficiency and Anemia in Pediatric Renal Transplant Recipients(2022) Avci, Begum; Baskin, Esra; Gulleroglu, Kaan; Yilmaz, Aysun Caltik; Karakaya, Emre; Moray, Gokhan; Haberal, Mehmet; 0000-0003-1434-3824; 0000-0002-5375-379X; 0000-0002-3462-7632; 0000-0002-4879-7974; AAJ-8833-2021; GYU-5220-2022; AAJ-8097-2021; AAD-5466-2021Item Preoperative Systemic Immune-Inflammation Index, Platelet-Lymphocyte Ratio and Neutrophil-Lymphocyte Ratio in Predicting the Delayed Graft Function in Pediatric Renal Transplant Recipients: A Single Centre Study(2022) Baskin, Esra; Siddiqui, Meraj Alam; Gulleroglu, Kaan Savas; Yilmaz, Aysun Caltik; Akdur, Aydincan; Moray, Gokhan; Haberal, Mehmet; 0000-0003-1434-3824; 0000-0002-5739-6590; 0000-0002-3462-7632; AAJ-8833-2021; ABF-7609-2022; AAJ-8097-2021Item Percutaneous Transhepatic TIPS for Budd-Chiari Syndrome As a Bridge to Liver Transplantation(2022) Boyvat, Fatih; Harman, Ali; Soy, Ebru H. Ayvazoglu; Ozen, Ozgur; Akdur, Aydincan; Moray, Gokhan; Haberal, Mehmet; 0000-0002-3462-7632; 0000-0001-7122-4130; AAJ-8097-2021; AAN-1681-2021Item Single Center Study on Liver Transplantation Since 1988: Expected Life Expectancy and Affecting Factors(2022) Erdal, Rengin; Arslan, Gulnaz; Moray, Gokhan; Boyacioglu, Sedat; Ozcay, Figen; Torgay, Adnan; Haberal, Mehmet; 0000-0002-6829-3300; 0000-0002-3462-7632; 0000-0002-5214-516X; AAJ-5221-2021; AAJ-8097-2021; ABG-5684-2020Item Posterior Reversible Encephalopathy Syndrome in Transplant Patients: Diagnosis and Management(2022) Karakaya, Emre; Kavasoglu, Lara; Akdur, Aydincan; Soy, Hatice Ebru Ayvazoglu; Moray, Gokhan; Haberal, Mehmet; 0000-0002-3462-7632; 0000-0002-4879-7974; AAJ-8097-2021; AAD-5466-2021Item Starting a New Life Thanks to a Successful Kidney Transplant After 30 Years of Hemodialysis: Case Report(2022) Karakaya, Emre; Akdur, Aydincan; Soy, Ebru H. Ayvazoglu; Sayin, Burak; Moray, Gokhan; Haberal, Mehmet; 0000-0002-4879-7974; 0000-0002-3462-7632; AAD-5466-2021; AAJ-8097-2021Item Eculizumab Therapy for Late Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients(2022) Siddiqui, Meraj Alam; Baskin, Esra; Karakayali, Feza Yarbug; Gemici, Atilla; Gulleroglu, Kaan; Yilmaz, Aysun Caltik; Moray, Gokhan; Haberal, Mehmet; 0000-0003-1434-3824; 0000-0002-3462-7632; AAJ-8833-2021; AAJ-8097-2021Item Predisposing Risk Factors in Liver Transplants Younger Than 3 Years(2022) Soy, Ebru H. Ayvazoglu; Akdur, Aydincan; Karakaya, Emre; Moray, Gokhan; Ozcay, Figen; Haberal, Mehmet; 0000-0002-5214-516X; 0000-0002-3462-7632; 0000-0002-4879-7974; ABG-5684-2020; AAJ-8097-2021; AAD-5466-2021Item COVID-19 Infections in Pediatric Renal Transplant Recipients(2022) Yilmaz, Aysun Caltik; Baskin, Esra; Gulleroglu, Kaan; Karakaya, Deniz; Akdur, Aydincan; Moray, Gokhan; Haberal, Mehmet; https://orcid.org/0000-0003-0774-4419; https://orcid.org/0000-0003-1434-3824; https://orcid.org/0000-0002-3462-7632; 35384829; AAD-1877-2021; AAJ-8833-2021; AAJ-8097-2021Objectives: The new coronavirus SARS-CoV-2 (COVID-19) first appeared in Turkey in March 2020, spread rapidly, and caused many deaths. Although COVID-19 is mostly a respiratory disease, it can cause kidney and multiorgan failure in some cases. We believe that by sharing information about the course and effects of COVID-19 infection in kidney transplant recipients receiving long-term immunosuppressive therapy our understanding will improve. Materials and Methods: Between March 2020 and October 2021, COVID-19 was researched in kidney transplant recipients under the age of 20 years who were followed at the Baskent University Transplantation Center. We documented the clinical characteristics and prognosis of pediatric kidney transplant recipients with COVID-19 disease. Results: Our study group included 23 patients with COVID-19 infection from 215 pediatric kidney transplant recipients. The mean age of the patients was 14.6 +/- 4.7 years; there were 9 female patients. The mean follow-up time posttransplant was 62.3 +/- 43.2 months. In 13 patients (56.5%), fever was the most frequent symptom. Most patients (n = 18, 78%) had minor symptoms and recovered completely after receiving supportive treatment. Four patients (17%) required hospitalization. One was diagnosed with COVID-19 infection 1 week after being treated with rituximab for acute antibody-mediated rejection. That patient died because of significant lung disease and multiorgan failure. Conclusions: Despite the fact that most of our pediatric transplant recipients had mild symptoms of COVID-19, we believe that particular caution should be observed in patients who have recently received intensive immunosuppressive medications. As a result of potential new vaccines, national immunization programs, and the emergence of novel virus strains, the clinical picture may change in the future. We believe that, as information sharing increases, we will learn more about COVID-19 in renal transplant recipients.